Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Spain
Rotigotine

AEMPS 2023

Rotigotine

Dariante 4 MG/24 Horas Parches Transdérmicos Efg

7,36 mg/24 h parche transdérmicoSpainMarketedAuthorised 17 Oct 2023

Product informationAsk Osler about it

On this page

In other countries
Packs
Documents
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

NEUPRO 2mg/24hRomania · 2mg/24h · plasture transdermic · Ucb Pharma S.A.Same strength and form
NEUPRO 4mg/24hRomania · 4mg/24h · plasture transdermic · Ucb Pharma S.A.Same strength and form
NEUPRO 6mg/24hRomania · 6mg/24h · plasture transdermic · Ucb Pharma S.A.Same strength and form
NeuproCanada · 8 MG / 24 HOUR · Patch · Ucb Canada INCSame form
NeuproCanada · 1 MG / 24 HOUR · Patch · Ucb Canada INCSame form
NeuproCanada · 2 MG / 24 HOUR · Patch · Ucb Canada INCSame form
KinparlevItaly · Cerotto transdermico · Orion CorporationSame form

More with the same substance on this register

Dariante 1 MG/24 Horas Parches Transdérmicos EfgRotigotine · 1,84 mg/24 h · parche transdérmicoSpain
Dariante 2 MG/24 Horas Parches Transdérmicos EfgRotigotine · 3,68 mg/24 h · parche transdérmico

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

NeuproItaly · Cerotto transdermico · Ucb Pharma S.A.

Same form

🇮🇹Rotigotina DocItaly · Cerotto transdermico · Doc Generici SRLSame form

🇳🇱Kinparlev 1 mg/24 uur pleister voor transdermaal gebruikNetherlands · Pleister voor transdermaal gebruik · Orion CorporationSame form

🇳🇱Kinparlev 2 mg/24 uur pleister voor transdermaal gebruikNetherlands · Pleister voor transdermaal gebruik · Orion CorporationSame form

🇳🇱Kinparlev 3 mg/24 uur pleister voor transdermaal gebruikNetherlands · Pleister voor transdermaal gebruik · Orion CorporationSame form

🇸🇦NEUPRO 2 mg/24 hrs Transdermal PatchesSaudi Arabia · LTS LOHMANN Therapie-SystemeSame form

🇸🇦Neupro 4 MG/24 HRS Transdermal PatchesSaudi Arabia · LTS LOHMANN Therapie-SystemeSame form

🇸🇦NEUPRO 6 mg/24 hrs Transdermal PatchesSaudi Arabia · LTS LOHMANN Therapie-SystemeSame form

🇧🇷NeuproBrazil · Ucb Biopharma Ltda.Same substance

🇪🇺NeuproEuropean Union · UCB Pharma S.A.Same substance

🇪🇺LegantoEuropean Union · UCB Pharma S.A.Same substance

🇪🇺Rotigotine MylanEuropean Union · Mylan S.A.SSame substance

🇭🇷NeuproCroatiaSame substance

🇺🇸NeuproUnited States · 1MG/24HR, 2MG/24HR, 3MG/24HR … · film, extended release · Ucb INCSame substance

Packs

Pack	Code	Status
DARIANTE 4 MG/24 HORAS PARCHES TRANSDÉRMICOS EFG, 28 parches	763600

Documents

The official texts, at the regulator.

Summary of product characteristicsAEMPS
Package leafletAEMPS
Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Rotigotine
Strength: 7,36 mg/24 h
Dosage form: parche transdérmico
Route: vía transdérmica
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 17 Oct 2023
Registration: 89092
Marketing authorisation holder: Exeltis Healthcare S.L.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica

🇪🇸Spain

AEMPSDariante 3 MG/24 Horas Parches Transdérmicos EfgRotigotine · 5,52 mg/24 h · parche transdérmico🇪🇸Spain

AEMPSDariante 6 MG/24 Horas Parches Transdérmicos EfgRotigotine · 11,04 mg/24 h · parche transdérmico🇪🇸Spain

AEMPSDariante 8 MG/24 Horas Parches Transdérmicos EfgRotigotine · 14,72 mg · parche transdérmico🇪🇸Spain

AEMPSNeupro 1 MG/24 H Parche TransdermicoRotigotine · 1 mg · parche transdérmico🇪🇸Spain

AEMPSNeupro 2 MG/24 H Parche TransdermicoRotigotine · 2 g · parche transdérmico🇪🇸Spain

AEMPSNeupro 3 MG/24 H Parche TransdermicoRotigotine · 3 mg · parche transdérmico🇪🇸Spain

AEMPSNeupro 4 MG/24 H Parche TransdermicoRotigotine · 4 g · parche transdérmico🇪🇸Spain

AEMPSNeupro 6 MG/24 H Parche TransdermicoRotigotine · 6 g · parche transdérmico🇪🇸Spain

AEMPSNeupro 8 MG/24 H Parche TransdermicoRotigotine · 8 g · parche transdérmico🇪🇸Spain

AEMPSKinparlev 1 MG/24 H Parche Transdermico EfgRotigotine · 2,2500 mg · parche transdérmico🇪🇸Spain